Cue Biopharma (CUE) Total Current Liabilities (2017 - 2025)
Historic Total Current Liabilities for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $15.5 million.
- Cue Biopharma's Total Current Liabilities fell 754.02% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 754.02%. This contributed to the annual value of $13.7 million for FY2024, which is 1985.83% down from last year.
- As of Q3 2025, Cue Biopharma's Total Current Liabilities stood at $15.5 million, which was down 754.02% from $19.3 million recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Total Current Liabilities registered a high of $19.3 million during Q2 2025, and its lowest value of $8.3 million during Q2 2022.
- For the 5-year period, Cue Biopharma's Total Current Liabilities averaged around $14.9 million, with its median value being $15.5 million (2025).
- In the last 5 years, Cue Biopharma's Total Current Liabilities crashed by 5008.1% in 2022 and then soared by 9592.69% in 2023.
- Cue Biopharma's Total Current Liabilities (Quarter) stood at $12.8 million in 2021, then dropped by 9.69% to $11.5 million in 2022, then soared by 47.91% to $17.1 million in 2023, then decreased by 19.86% to $13.7 million in 2024, then increased by 13.4% to $15.5 million in 2025.
- Its last three reported values are $15.5 million in Q3 2025, $19.3 million for Q2 2025, and $15.5 million during Q1 2025.